sunitinib - Robuta Search

https://adisinsight.springer.com/drugsafety/803119165?error=cookies_not_supported&code=55479734-b090-48cc-9800-7393d8694eb8 Sunitinib - AdisInsight In a retrospective study of 155 patients, aged 18 years or older, 1 patient [age and sex not stated] was identified to have developed nephrotic syndrome during sunitinib adisinsight https://seer.cancer.gov/oncologytoolbox/canmed/hcpcs/1143/ Sunitinib malate - CanMED: HCPCS CanMED: HCPCS. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. sunitinib malate hcpcs https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-sunitinib-and-nivolumab-for-sarcoma-immunosarc2-0 A trial of sunitinib and nivolumab for sarcoma (ImmunoSarc2) This trial is looking at sunitinib with nivolumab. It is for people whose soft tissue sarcoma or bone sarcoma has come back after treatment. trial sunitinib nivolumab sarcoma https://researchconnect.buffalo.edu/en/publications/everolimus-versus-sunitinib-for-patients-with-metastatic-non-clea/ Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma... for patients https://pubmed.ncbi.nlm.nih.gov/23660867/?dopt=Abstract Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final... Preliminary results demonstrated that concurrent sunitinib and stereotactic body radiation therapy (SBRT) is an active regimen for metastases limited in number... for patients concurrent sunitinib stereotactic body https://health.economictimes.indiatimes.com/tag/sunitinib Sunitinib - Latest sunitinib , Information & Updates - Health -ET HealthWorld ETHealthworld.com brings latest sunitinib news, views and updates from all top sources for the Indian Health industry. latest information sunitinib updates health et https://adisinsight.springer.com/trials/700259726?error=cookies_not_supported&code=1fedc199-d708-43a7-ad9b-49311fe49bfa Tumour biomarkers for sunitinib response in patients with advanced renal cell carcinoma -... This retrospective study investigated tumour biomarkers for sunitinib response in patients with advanced renal cell carcinoma. Patients identified from the in patients https://adisinsight.springer.com/drugsafety/803927217?error=cookies_not_supported&code=d27a4b01-723f-447a-a750-3c770c3fc40e Sunitinib/Nivolumab - AdisInsight Patients aged 12 to 80 years [sex not stated] with advanced, progressive clear cell sarcoma received sunitinib at 37.5 mg/day for the first 2 weeks then 25 sunitinib nivolumab adisinsight https://adisinsight.springer.com/drugsafety/803053184?error=cookies_not_supported&code=777c118e-c971-43ae-9670-d41fde6089cd Sunitinib - AdisInsight Two patients with renal cell carcinoma [age and sex not stated] underwent nephrectomy and subsequently started treatment with sunitinib on a 4-week on, 2-week sunitinib adisinsight https://adisinsight.springer.com/trials/700199935?error=cookies_not_supported&code=0458fa39-8733-40dd-b41a-1d4bd1496df0 A Phase II Study Of Sunitinib And Low Dose Metronomic Cyclophosphamide In Advanced Renal Cell... This trial will investigate the efficacy and tolerability of sunitinib [Sutent] and low dose metronomic cyclophosphamide in patients with advanced or metastatic https://researchportalplus.anu.edu.au/en/publications/response-of-carneys-triad-related-metastatic-gastrointestinal-str/ Response of Carney's triad-related metastatic gastrointestinal stromal tumor to sunitinib - The... https://pubmed.ncbi.nlm.nih.gov/26784451/ Hypothyroidism Side Effect in Patients Treated with Sunitinib or Sorafenib: Clinical and Structural... Tyrosine kinase inhibitors (TKIs) provide more effective targeted treatments for cancer, but are subject to a variety of adverse effects, such as... https://scholars.duke.edu/publication/1405624 Scholars@Duke publication: The efficacy and safety of sunitinib in patients with advanced... efficacy and safety https://adisinsight.springer.com/drugsafety/803378521?error=cookies_not_supported&code=115a9d39-8f61-4893-8475-19b10d1ccb2d Sunitinib - AdisInsight A 63-year-old woman developed acute pancreatitis, acute renal failure (worsening of chronic kidney failure), pancytopenia and urinary infection during treatment sunitinib adisinsight https://pubmed.ncbi.nlm.nih.gov/28895069/ Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of... Despite the small sample size and retrospective nature, we demonstrated the feasibility, safety, and efficacy of the alternative schedule, allowing prolonged... safety and efficacy https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT00375674&r=1 A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of... A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer efficacy and safety https://pubmed.ncbi.nlm.nih.gov/31427204/ Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell... Bristol-Myers Squibb and ONO Pharmaceutical. https://www.news-medical.net/news/20150225/Sorafenib-sunitinib-provide-no-benefit-to-patients-with-locally-advanced-kidney-cancer.aspx Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer Jun 18, 2019 - Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery)... to patients https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2018-01041&r=1 Cabozantinib or Sunitinib Malate in Treating Participants with Metastatic Variant Histology Renal... Cabozantinib or Sunitinib Malate in Treating Participants with Metastatic Variant Histology Renal Cell Carcinoma https://pure.psu.edu/en/publications/prospective-clinical-trial-of-preoperative-sunitinib-in-patients-/ Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma - Penn... https://seer.cancer.gov/oncologytoolbox/canmed/hcpcs/1145/ Sunitinib malate - CanMED: HCPCS CanMED: HCPCS. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. sunitinib malate hcpcs https://news.cancerresearchuk.org/2009/02/04/nice-recommends-sutent-sunitinib-for-advanced-kidney-cancer/ NICE recommends Sutent (sunitinib) for advanced kidney cancer - Cancer Research UK - Cancer News Apr 12, 2021 - Six months after their preliminary decision, the National Institute of Health and Clinical Excellence (NICE) today issued its final guidance on the... cancer research uk for advanced nice recommends sutent https://pubmed.ncbi.nlm.nih.gov/25075067/ Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter... Clinical outcome of the metastatic non-clear cell RCC patients with sunitinib treatment seemed to be worse than the historical data of clear cell RCC patients,... for patients https://researchconnect.buffalo.edu/en/publications/longitudinal-assessment-of-vascular-function-with-sunitinib-in-pa/ Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell... https://pubmed.ncbi.nlm.nih.gov/33246931/ Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell... ClinicalTrials.gov identifier: NCT02231749. https://adisinsight.springer.com/drugsafety/803415480?error=cookies_not_supported&code=ea800285-b2bc-4eba-888e-ba343cfff436 Sunitinib - AdisInsight An approximately 69-year-old woman developed thrombotic microangiopathy (TMA) and thrombocytopenia during treatment with sunitinib for metastatic renal cell sunitinib adisinsight https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/16714-0679/ 16714-0679 Sunitinib malate - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. sunitinib malate ndc https://pubmed.ncbi.nlm.nih.gov/27175586/ Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib... a retrospective analysis on 97 histologic samples of mRCC patients was conducted for VEGF-A, VEGF-C and VEGFR-1,2,3 single nucleotide polymorphisms (SNPs). https://adisinsight.springer.com/drugsafety/803925662?error=cookies_not_supported&code=630c5829-b73e-4126-8d37-215360bf2f27 Sunitinib - AdisInsight A 60-year-old woman with metastatic renal cell carcinoma developed thrombotic microangiopathy and pyoderma gangrenosum after prolonged treatment with sunitinib. sunitinib adisinsight https://adisinsight.springer.com/trials/700263845?error=cookies_not_supported&code=d6062966-5520-46cc-a897-86884e728f85 A retrospective study to evaluate to safety and efficacy of Sunitinib in patients with metastatic... This retrospective study investigated safety and efficacy of Sunitinib in patients with metastatic renal cell carcinoma (mRCC). https://pubmed.ncbi.nlm.nih.gov/20843836/ Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients:... The adverse effects of sunitinib, particularly on the hematopoietic system, may be rapid and appear directly related to its activity in HCC. This exploratory... exploratory analysis hepatocellular carcinoma early toxicity https://adisinsight.springer.com/drugsafety/803567655?error=cookies_not_supported&code=4c4dbc41-2860-4a28-81cd-b4b7ca612f15 Nivolumab/prednisolone/sunitinib - AdisInsight A 62-year-old man developed thyrotoxicosis and hyperglycaemia during treatment with sunitinib and prednisolone, respectively. Additionally, he developed type 1 nivolumab prednisolone sunitinib adisinsight https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/82293-0015/ 82293-0015 Sunitinib Malate - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. sunitinib malate ndc https://pubmed.ncbi.nlm.nih.gov/23626551/ Targeting VEGF-VEGFR Pathway by Sunitinib in Peripheral Primitive Neuroectodermal Tumor,... Sunitinib malate (Sutent(TM); Pfizer Inc., New York, N.Y., USA) is a small molecule kinase inhibitor with activity against a number of tyrosine kinase... targeting vegf pathway https://adisinsight.springer.com/patents/800017413 Sunitinib - Pfizer - AdisInsight sunitinib pfizer adisinsight https://scholars.duke.edu/publication/1405638 Scholars@Duke publication: The Efficacy and Safety of Sunitinib in Patients With Advanced... efficacy and safety https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-everolimus-and-sunitinib-for-advanced-kidney-cancer A trial looking at the order in which everolimus and sunitinib should be given for advanced kidney... This trial compared 2 different orders (sequences) of having everolimus and sunitinib for kidney cancer that had spread to other parts of the body. https://adisinsight.springer.com/drugsafety/803068602?error=cookies_not_supported&code=0cbf326d-7e53-432a-9066-db0c6639c92f Sorafenib/sunitinib - AdisInsight Three patients developed pneumatosis intestinalis during treatment with sorafenib or sunitinib [routes not stated] for the treatment of cancer metastases.A sorafenib sunitinib adisinsight https://research.utwente.nl/en/publications/sunitinib-microspheres-based-on-pdlla-peg-pdlla-b-plla-multi-bloc/ Sunitinib microspheres based on [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers for ocular drug... https://tobias-lib.ub.uni-tuebingen.de/xmlui/handle/10900/65387 A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with... https://adisinsight.springer.com/drugsafety/803138553?error=cookies_not_supported&code=61e629af-9d39-4260-86ba-faacc35ab0e5 Sunitinib - AdisInsight A 28-year-old woman developed cardiotoxicity during treatment with sunitinib for clear cell sarcoma.The woman was diagnosed with CCS of her left foot in 2007. sunitinib adisinsight https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT03141177&r=1 A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated... A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma https://pubmed.ncbi.nlm.nih.gov/39098455/ Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell... Superior survival, durable response benefits, and a manageable safety profile were maintained with NIVO+IPI versus SUN at 8 years, the longest phase III... https://scholars.duke.edu/publication/1405547 Scholars@Duke publication: Efficacy and Safety of Sunitinib in Patients with Well-Differentiated... efficacy and safety https://adisinsight.springer.com/trials/700392156?error=cookies_not_supported&code=789b69c5-8cee-4472-a2f4-b74b35ec5f80 A Phase 2 trial investigating the benefit of the bezuclastinib plus sunitinib combination for... A Phase 2 trial investigating the benefit of the bezuclastinib plus sunitinib combination for first-line GIST patients with exon 9 mutations who are naive to, https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2019-06119&r=1 Losartan and Sunitinib for the Treatment of Relapsed or Refractory Osteosarcoma - NCI Losartan and Sunitinib for the Treatment of Relapsed or Refractory Osteosarcoma for the https://pubmed.ncbi.nlm.nih.gov/29562145/?dopt=Abstract Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk... nivolumab plus ipilimumab versus sunitinib https://adisinsight.springer.com/drugsafety/803928690?error=cookies_not_supported&code=e796ba4c-e7b0-4078-a06d-188dd19bd9bb Axitinib/Sunitinib/Toripalimab - AdisInsight A 57-year-old man with stage IVB clear cell renal cell carcinoma and metastatic recurrence experienced progressive dyspnoea, chest tightness, hypoxaemia, axitinib sunitinib adisinsight https://pubmed.ncbi.nlm.nih.gov/33284113/ Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal... https://pubmed.ncbi.nlm.nih.gov/31035254/ EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR? Broncho-pulmonary neuroendocrine neoplasms (BP-NENs) are neoplasms orphan of an efficient therapy. Available medical treatments derived from clinical trials... https://scholars.uky.edu/es/publications/a-phase-i-pharmacodynamic-trial-of-sequential-sunitinib-with-beva/fingerprints/ A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal... https://adisinsight.springer.com/drugsafety/801026847?error=cookies_not_supported&code=03d51424-32a1-4a8f-b4ea-6c74b8b412d8 Imatinib/sunitinib - AdisInsight A 73-year-old woman developed hypothyroidism while receiving imatinib, then sunitinib, for metastatic gastrointestinal stromal cancer.The woman was receiving imatinib sunitinib adisinsight https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/00378-6681/ 00378-6681 Sunitinib Malate - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. sunitinib malate ndc https://pubmed.ncbi.nlm.nih.gov/21113349/ Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in... The prognosis of patients with advanced hepatocellular carcinoma (HCC) is very poor. The outcome of these patients is particularly bleak when the disease is... https://www.pfizer.com/science/clinical-trials/plain-language-study-results-summaries/study-avelumab-axitinib-versus A study of Avelumab with Axitinib Versus Sunitinib in Advanced Renal Cell Cancer (JAVELIN Renal... https://adisinsight.springer.com/drugsafety/803051981?error=cookies_not_supported&code=62d32c52-3fc9-4ee8-b586-b8e8845ab2a6 Amlodipine/sunitinib - AdisInsight Two patients developed toxic psychosis during treatment with sunitinib for metastatic renal cell cancer. One patient was also receiving amlodipine, which was amlodipine sunitinib adisinsight